IL-17 Role in Variants of Psoriasis

NCT02078297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2015-03-27

No results posted yet for this study

Summary

The goal of this project is to study some mechanisms involved in the dysregulation of the immune system observed in the skin of subjects with psoriasis. This will be done by analyzing specific immune cells as well as gene and protein expression in small skin samples (biopsies) from patients with psoriasis. These results will be compared to the skin of healthy subjects without psoriasis.

Conditions

  • Scalp Psoriasis
  • Pustular Palmo-plantar Psoriasis
  • Non-pustular Palmo-plantar Psoriasis
  • Elbow Psoriasis
  • Lower Leg Psoriasis

Sponsors & Collaborators

  • Innovaderm Research Inc.

    lead OTHER

Principal Investigators

  • Robert Bissonnette, MD · Innovaderm Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-02-28
Completion
2015-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02078297 on ClinicalTrials.gov